Kulze III John C MD Charleston, SC - 29414

Kulze III John C MD is categorized under Family Practice Doctors in Charleston, SC and active since 1997.

Kulze III John C MD was established in 1997, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact John Kulze III at the company’s single location by writing to 2270 Ashley Crossing Drive # 100, Charleston, South Carolina SC 29414 or by phoning (843) 556-2357. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Kulze III John C MD
Contact Person: John Kulze III
Address: 2270 Ashley Crossing Drive # 100, Charleston, South Carolina 29414
Phone Number: (843) 556-2357
Website Address: eyecentersc.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 1997
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Family Practice Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Kulze III John C MD was started in 1997 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact John Kulze III for inquiries that concern Kulze III John C MD by calling the company number (843) 556-2357, as your correspondence is most welcome. Additionally, the physical location of the single location of Kulze III John C MD can be found at the coordinates 32.81255,-80.03887 as well as the street address 2270 Ashley Crossing Drive # 100 in Charleston, South Carolina 29414.

For its online presence, you may visit Kulze III John C MD’s website at eyecentersc.com and engage with its social media outlets through on Twitter and on Facebook.